Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Pharmaceutical Biotechnology
  4. Volume 26, Issue 4
  5. Article
Volume 26, Issue 4
  • ISSN: 1389-2010
  • E-ISSN: 1873-4316

Abstract

Background

Atherosclerosis (AS) is a chronic inflammatory disease characterized by the accumulation of lipids, the formation of lesion plaques, and the narrowing of arterial lumens. Rhubarb has significant effects against AS, but there is a lack of analysis and exploration of the mechanism of action of the transitional components in serum containing rhubarb.

Objective

This work aims to combine serum pharmacochemistry, network pharmacology, and molecular docking to explore active ingredients and mechanism of rhubarb against AS.

Methods

Firstly, the components of rhubarb in blood samples were identified using HPLC-Q-TOF/MS. The ingredients-targets-disease interaction network of rhubarb was constructed through network pharmacology. Then, molecular docking between the ingredients and the core targets was carried out using the Autodock Vina software.

Results

Eleven active ingredients and five metabolites were preliminarily identified. The network pharmacology results showed that chrysophanol, resveratrol, and emodin might have potential pharmacological effects on AS. The PPI network showed that the key proteins were PTGS2, ESR1, PTGS1, and ELANE. GO analysis revealed that genes were mainly enriched in the inflammatory response and response to exogenous stimuli. Moreover, these genes were related to IL-17 signaling pathways, lipid and atherosclerosis, and other pathways. Molecular docking analyses showed that chrysophanol and emodin have strong binding affinities with the target proteins PTGS2 and PTGS1.

Conclusion

A comprehensive strategy combining serum pharmacochemistry with network pharmacology and molecular docking was employed to investigate the active ingredients and the mechanism of rhubarb in treating AS, which provided a basis for studying the pharmacological effects and action mechanisms of rhubarb.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpb/10.2174/0113892010296117240531071301
2024-06-06
2025-03-29

  • From This Site

    /content/journals/cpb/10.2174/0113892010296117240531071301
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. FernandezH.B. BrisG.R. CrespoS.B. GranadoG.J.M. Immunobiology of atherosclerosis: A complex net of interactions.Int. J. Mol. Sci.20192021529310.3390/ijms2021529331653058
     [Google Scholar]
  2. TangZ.W. GuY.M. XueM. Study on prevention and treatment of atherosclerosis with chinese medicine based on immune inflammation theory.J. Basic Clin. Med.2022281192119810.19945/j.cnki.issn.1006‑3250.2022.07.021
     [Google Scholar]
  3. ZhiW. LiuY. WangX. ZhangH. Recent advances of traditional Chinese medicine for the prevention and treatment of atherosclerosis.J. Ethnopharmacol.202330111574910.1016/j.jep.2022.11574936181983
     [Google Scholar]
  4. GuoJ.R. Research progress on lipid-regulating and antiatherosclerosis effect of chinese medicine.Chin Med Mod Distance Educ China202321200202
     [Google Scholar]
  5. WangX.J. Pharmacometabonomics-based elucidation of thesyner-getic effects of multi-component TCMs and related medi-cal formula.Chin. J. Nat. Med.200972909410.3724/SP.J.1009.2009.00090
     [Google Scholar]
  6. ZhangA. SunH. QiuS. WangX. Advancing drug discovery and development from active constituents of yinchenhao tang, a famous traditional chinese medicine formula.Evid. Based Complement. Alternat. Med.201320131610.1155/2013/25790924191164
     [Google Scholar]
  7. ChenJ. ChenQ.L. Current situation and thinking of network pharmacology in the research of traditional Chinese medicine.Acad J Shanghai Univ Tradit Chin Med202135110.16306/j.1008‑861x.2021.05.001
     [Google Scholar]
  8. ZhouK. LuD. YouJ. LiuT. SunJ. LuY. PanJ. LiY. LiuC. Integrated plasma pharmacochemistry and network pharmacology to explore the mechanism of gerberae piloselloidis herba in treatment of allergic asthma.J. Ethnopharmacol.202229811562410.1016/j.jep.2022.11562435970314
     [Google Scholar]
  9. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China 2020BeiJingChina Medical Science Press20201
     [Google Scholar]
  10. TangX. ZhangY. LiuX. LiX. ZhaoH. CuiH. ShiY. ChenY. XuH. MengZ. ZhaoL. ChenH. WangZ. ZhuM. LinY. YangB. ZhangY. Aloe-emodin derivative produces anti-atherosclerosis effect by reinforcing AMBRA1-mediated endothelial autophagy.Eur. J. Pharmacol.202291617464110.1016/j.ejphar.2021.17464134800465
     [Google Scholar]
  11. ZhangL. TianW.Y. WangH.S. LaiC.C. LiM.J. XiaL. Shouwu emodin against ApoE-/- mouse atherosclerosis based on PI3K/AKT/mTOP signaling pathway.Chin. J. Chin. Mater. Medica.20214127692773
     [Google Scholar]
  12. WangY.Q. LiS.J. ZhuangG. GengR.H. JiangX. Screening free radical scavengers in Xiexin Tang by HPLC‐ABTS‐DAD‐Q‐TOF/MS.Biomed. Chromatogr.20173111e400210.1002/bmc.400228477383
     [Google Scholar]
  13. GodzienJ. CiborowskiM. AnguloS. RuperezF.J. Paz MartínezM. SeñoransF.J. CifuentesA. IbañezE. BarbasC. Metabolomic approach with LC-QTOF to study the effect of a nutraceutical treatment on urine of diabetic rats.J. Proteome Res.201110283784410.1021/pr100993x21087057
     [Google Scholar]
  14. SuZ.H. LiS.Q. ZouG.A. YuC.Y. SunY.G. ZhangH.W. GuY. ZouZ.M. Urinary metabonomics study of anti-depressive effect of Chaihu-Shu-Gan-San on an experimental model of depression induced by chronic variable stress in rats.J. Pharm. Biomed. Anal.201155353353910.1016/j.jpba.2011.02.01321398066
     [Google Scholar]
  15. LeiQ.L. HuangY.L. ZhongQ. LiangJ. WuY.Q. SuQ. Anti-inflammatory mechanism of scutellarlae radix based on network pharmacology.Chin. Tradit. Herbal Drugs20182435233530
     [Google Scholar]
  16. LiJ.S. ZhaoZ.Z. MiaoX.D. SuS.L. ShangE.X. QianD.W. DuanJ.A. Mechanism of Olibanum-Myrrha in treatment of rheumatoid arthritis based on network pharmacology and molecular docking.Chin. J. Chin. Mater. Med.202146102371237934047081
     [Google Scholar]
  17. LiuS. Study on applications of liquid chromatography tandem mass spectrometryin components of rheum officinale baill radix scutellariae and abelmoschus manihot in vivo.Thesis; Harbin University of Commerce2011
     [Google Scholar]
  18. LiuY.J. WangQ. JiangM. LiH.Y. ZouM.J. BaiG. Screening of effective components for inhibition of tryosinase actitity in rhubarb based on spectrum-efficiency-structure-activity relationship.Chin. Tradit. Herbal Drugs20124321202126
     [Google Scholar]
  19. AblajanK. AblizZ. ShangX.Y. HeJ.M. ZhangR.P. ShiJ.G. Structural characterization of flavonol 3,7‐di‐ O ‐glycosides and determination of the glycosylation position by using negative ion electrospray ionization tandem mass spectrometry.J. Mass Spectrom.200641335236010.1002/jms.99516432803
     [Google Scholar]
  20. SunH. ZhuC. ZhangH.Y. WangY.R. LuoG.A. HuP. Comparative analysis of main constituents of Radix et Rhizoma Rhei and processed Radix et Rhizoma Rhei by HPLC-ESI-TOF-MS.Zhongchengyao200931420424
     [Google Scholar]
  21. GaoL.L. Studies on the chemical constituents and biological activity of Rheum tanguticum Maxim. ex Balf., Rheum officinale Baill. and Rheum palmatum L..D. Sc. Thesis, Graduate School of Peking Union Medical College, Beijing.2012
     [Google Scholar]
  22. LiuY. LiY. ZhaoL.B. FangY. FengW.Y. Study on the fragmentation pathways of 4 kinds of resveratrol compounds by ESI-MS.China Pharm2013243336
     [Google Scholar]
  23. LiL.Y. WangY. LiuM.J. ZhangX. LiX.Q. DaiY.J. Analysis of chemical components in zhizi jinhua wan by UPLC-Q-TOF-MS/MS.Chin. J. Exper. Med. Formulae20172311110.13422/j.cnki.syfjx.2017140001
     [Google Scholar]
  24. FalkE. Pathogenesis of atherosclerosis.J. Am. Coll. Cardiol.200647S8C7C1210.1016/j.jacc.2005.09.06816631513
     [Google Scholar]
  25. FanJ. WatanabeT. Atherosclerosis: Known and unknown.Pathol. Int.202272315116010.1111/pin.1320235076127
     [Google Scholar]
  26. WangC. NiimiM. WatanabeT. WangY. LiangJ. FanJ. Treatment of atherosclerosis by traditional Chinese medicine: Questions and quandaries.Atherosclerosis201827713614410.1016/j.atherosclerosis.2018.08.03930212682
     [Google Scholar]
  27. LiuX. WuJ. TianR. SuS. DengS. MengX. Targeting foam cell formation and macrophage polarization in atherosclerosis: The Therapeutic potential of rhubarb.Biomed. Pharmacother.202012911043310.1016/j.biopha.2020.11043332768936
     [Google Scholar]
  28. MaX.H. ShenS.L. HanF.M. ChenY. The electrospray ionization-mass spectra of Radix et rhizoma rhei anthraquinones.In: J Hubei Univ Sci20062006403406
     [Google Scholar]
  29. WangY.Q. YanM. ChenW. YangY.Y. Pilot study on serum pharmacochemistry of fructus psoraleae.Chin. J. New Drugs20082008396399
     [Google Scholar]
  30. WangY.J. FengS.H. ChengJ.T. ChenS. Research progress on chemical constituents and pharmacological action of anthraquinone in rhei radix et rhizoma.Chin. J. Exper. Trad. Med. Formulae.20182422723410.13422/j.cnki.syfjx.20181020
     [Google Scholar]
  31. LiL ZhangC XiaoYQ ChenDD TianGF WangY Quantitative determination of butyrophenone and stilbene constituents in Dahuang(Radix et Rhizoma Rhei).J Beijing Univ Tradit Chin Med201033670672+675
     [Google Scholar]
  32. JiaY.M. WangJ.M. CuiY. Research progress in pharmacological actions of rhizomn polygoni cuspidati based on stilbene compounds as main bioactive components.Chin. J. Exper. Med. Formul.20111726326910.13422/j.cnki.syfjx.2011.09.080
     [Google Scholar]
  33. MihailovicP.M. LioW.M. YanoJ. ZhouJ. ZhaoX. ChyuK.Y. ShahP.K. CercekB. DimayugaP.C. IL-7R blockade reduces post-myocardial infarction-induced atherosclerotic plaque inflammation in ApoE−/- mice.Biochem. Biophys. Rep.20191910064710.1016/j.bbrep.2019.10064731193072
     [Google Scholar]
  34. ShiX.X. The study on the regulation mechanism of CCL20 and IL-17 in RAW264.7 and their correlations with coronary heart disease..Thesis; Southern Medical University2018
     [Google Scholar]
  35. MladosievicovaB. PetrikovaL. ValaskovaZ. BernadicM.Jr ChovanecM. MegoM. BernadicM.Sr Atherosclerosis in cancer patients.Bratisl. Med. J.2019120963664010.4149/BLL_2019_10531475545
     [Google Scholar]
  36. BalzanS. LubranoV. LOX-1 receptor: A potential link in atherosclerosis and cancer.Life Sci.2018198798610.1016/j.lfs.2018.02.02429462603
     [Google Scholar]
/content/journals/cpb/10.2174/0113892010296117240531071301
Loading
Integrated Serum Pharmacochemistry, Network Pharmacology, and Molecular Docking to Study the Mechanism of Rhubarb against Atherosclerosis
Current Pharmaceutical Biotechnology 26, 564 (2025); https://doi.org/10.2174/0113892010296117240531071301
/content/journals/cpb/10.2174/0113892010296117240531071301
/content/journals/cpb/10.2174/0113892010296117240531071301
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): atherosclerosis; HPLC-Q-TOF/MS; molecular docking; network pharmacology; Rhubarb; serum pharmacochemistry

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test